Cripto-1 vaccination elicits protective immunity against metastatic melanoma

References

• Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011; 480:480-9; PMID:22193102; http://dx.doi.org/10.1038/nature10673
   PubMed Web of Science ®Google Scholar
• Shin DS, Ribas A. The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? Curr Opin Immunol 2015; 33:23-35; PMID:25621841; http://dx.doi.org/10.1016/j.coi.2015.01.006
   PubMed Web of Science ®Google Scholar
• Pardoll DM. Immunology beats cancer: a blueprint for successful translation. Nat Immunol 2012; 13:1129-32; PMID:23160205; http://dx.doi.org/10.1038/ni.2392
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 2009; 21:233-40; PMID:19304471; http://dx.doi.org/10.1016/j.coi.2009.03.002
   PubMed Web of Science ®Google Scholar
• Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, Walsh LA, Postow MA, Wong P, Ho TS et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma. N Engl J Med 2014; 371:2189-99; PMID:25409260; http://dx.doi.org/10.1056/NEJMoa1406498
   PubMed Web of Science ®Google Scholar
• Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 2015; 348:124-8; PMID:25765070; http://dx.doi.org/10.1126/science.aaa1348
   PubMed Web of Science ®Google Scholar
• Dougan M, Dranoff G. Immune therapy for cancer. Annu Rev Immunol 2009; 27:83-117; PMID:19007331; http://dx.doi.org/10.1146/annurev.immunol.021908.132544
   PubMed Web of Science ®Google Scholar
• Finn OJ. Cancer vaccines: between the idea and the reality. Nat Rev Immunol 2003; 3:630-41; PMID:12974478; http://dx.doi.org/10.1038/nri1150
   PubMed Web of Science ®Google Scholar
• Schmidt P, Abken H. The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth. Oncotarget 2011; 2:313-20; PMID:21487158; http://dx.doi.org/10.18632/oncotarget.259
   PubMed Web of Science ®Google Scholar
• Bianco C, Salomon DS. Targeting the embryonic gene Cripto-1 in cancer and beyond. Expert Opin Ther Pat 2010; 20:1739-49; PMID:21073352; http://dx.doi.org/10.1517/13543776.2010.530659
   PubMed Web of Science ®Google Scholar
• Bianco C, Strizzi L, Normanno N, Khan N, Salomon DS. Cripto-1: An oncofetal gene with many faces. Curr Top Dev Biol 2005; 67:85-133; PMID:15949532; http://dx.doi.org/10.1016/S0070-2153(05)67003-2
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Strizzi L, Margaryan NV, Gilgur A, Hardy KM, Normanno N, Salomon DS, Hendrix MJC. The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics. Cell Cycle 2013; 12:1450-6; PMID:23574716; http://dx.doi.org/10.4161/cc.24601
   PubMed Web of Science ®Google Scholar
• Schlaak M, Schmidt P, Bangard C, Kurschat P, Mauch C, Abken H. Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. Oncotarget 2012; 3:22-30; PMID:22289880; http://dx.doi.org/10.18632/oncotarget.437
   PubMed Web of Science ®Google Scholar
• Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos A, Roos A-K, Quest AFG, Kiessling R. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma. Cancer Immunol Immunother 2009; 59:81-92; PMID:19526360; http://dx.doi.org/10.1007/s00262-009-0725-4
   PubMed Web of Science ®Google Scholar
• Wechselberger C, Wechselberger C, Ebert A, Ebert AD, Bianco C, Bianco C, Khan NI, Khan NI, Sun Y, Sun Y et al. Cripto-1 Enhances Migration and Branching Morphogenesis of Mouse Mammary Epithelial Cells. Exp Cell Res 2001; 266:95-105; PMID:11339828; http://dx.doi.org/10.1006/excr.2001.5195
   PubMed Web of Science ®Google Scholar
• Ligtenberg MA, Rojas-Colonelli N, Kiessling R, Lladser A. NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses. Hum Vaccin Immunother 2014; 9:2189-95; PMID:23884215; http://dx.doi.org/10.4161/hv.25699
   Web of Science ®Google Scholar
• Kato M, Kato M, Takahashi M, Takahashi M, Akhand AA, Akhand AA, Liu W, Liu W, Dai Y, Dai Y et al. Transgenic mouse model for skin malignant melanoma. Oncogene 1998; 17:1885-8; PMID:9778055; http://dx.doi.org/10.1038/sj.onc.1202077
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model. Life Sci 2002; 70:791-8; PMID:11833741; http://dx.doi.org/10.1016/S0024-3205(01)01454-0
   PubMed Web of Science ®Google Scholar
• Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197:893-5; PMID:887927; http://dx.doi.org/10.1126/science.887927
   PubMed Web of Science ®Google Scholar
• Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, la Grange de P, Khatib A-M, Aoudjit F, Charron D, Alcaide-Loridan C et al. Melanoma Spheroids Grown Under Neural Crest Cell Conditions Are Highly Plastic Migratory/Invasive Tumor Cells Endowed with Immunomodulator Function. PLoS One 2011; 6:e18784; PMID:21526207; http://dx.doi.org/10.1371/journal.pone.0018784
   PubMed Web of Science ®Google Scholar
• Mo J, Sun B, Zhao X, Gu Q, Dong X, Liu Z, Ma Y, Zhao N, Liu Y, Chi J et al. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines. Melanoma Res 2013; 23(4):254-63
   PubMed Web of Science ®Google Scholar
• Su AI, Su AI, Wiltshire T, Wiltshire T, Batalov S, Batalov S, Lapp H, Lapp H, Ching KA, Ching KA et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004; 101:6062-7; PMID:15075390; http://dx.doi.org/10.1073/pnas.0400782101
   PubMed Web of Science ®Google Scholar
• Bloom MB, Perry-Lalley D, Robbins PF, Li Y, El-Gamil M, Rosenberg SA, Yang JC. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med 1997; 185:453-9; PMID:9053445; http://dx.doi.org/10.1084/jem.185.3.453
   PubMed Web of Science ®Google Scholar
• Wicha MS. Cancer Stem Cells: An Old Idea–A Paradigm Shift. Cancer Res 2006; 66:1883-90. Available from; PMID:16488983; http://dx.doi.org/10.1158/0008-5472.CAN-05-3153
   PubMed Web of Science ®Google Scholar
• De Luca A, Lamura L, Strizzi L, Roma C, D'Antonio A, Margaryan N, Pirozzi G, Hsu M-Y, Botti G, Mari E et al. Expression and functional role of CRIPTO-1 in cutaneous melanoma. Br J Cancer 2011; 105:1030-8; PMID:21863025; http://dx.doi.org/10.1038/bjc.2011.324
   PubMed Web of Science ®Google Scholar
• Mallikarjuna K, Vaijayanthi P, Krishnakumar S. Cripto-1 expression in uveal melanoma: An immunohistochemical study. Exp Eye Res 2007; 84:1060-6; PMID:17412323; http://dx.doi.org/10.1016/j.exer.2007.01.019
   PubMed Web of Science ®Google Scholar
• Bianco C, Rangel MC, Castro NP, Nagaoka T, Rollman K, Gonzales M, Salomon DS. Role of Cripto-1 in stem cell maintenance and malignant progression. Am J Pathol 2010; 177:532-40; PMID:20616345; http://dx.doi.org/10.2353/ajpath.2010.100102
   PubMed Web of Science ®Google Scholar
• Pagès F, Galon J, Galon J, Dieu-Nosjean M-C, Tartour E, Sautès-Fridman C, Fridman W-H. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2009; 29:1093-102; PMID:23884215; http://dx.doi.org/10.1038/onc.2009.416
   PubMed Web of Science ®Google Scholar
• Gross S, Geldmacher A, Sharav T, Losch F, Walden P. Immunosuppressive mechanisms in cancer: Consequences for the development of therapeutic vaccines. Vaccine 2009; 27:3398-400; PMID:19200836; http://dx.doi.org/10.1016/j.vaccine.2009.01.070
   PubMed Web of Science ®Google Scholar
• Schmidt P, Kopecky C, Hombach A, Zigrino P, Mauch C, Abken H. Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc Natl Acad Sci USA 2011; 108:2474-9; PMID:21282657; http://dx.doi.org/10.1073/pnas.1009069108
   PubMed Web of Science ®Google Scholar
• Watanabe K, Nagaoka T, Lee JM, Bianco C, Gonzales M, Castro NP, Rangel MC, Sakamoto K, Sun Y, Callahan R et al. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1. J Cell Biol 2009; 187:343-53; PMID:19948478; http://dx.doi.org/10.1083/jcb.200905105
   PubMed Web of Science ®Google Scholar
• Ljunggren HG, Ljunggren H-G, Stam NJ, Stam NJ, Ohlén C, Öhlén C, Neefjes JJ, Neefjes JJ, Höglund P, Höglund P et al. Empty MHC class I molecules come out in the cold. Nature 1990; 346:476-80; PMID:2198471; http://dx.doi.org/10.1038/346476a0
   PubMed Web of Science ®Google Scholar